Works matching Myeloma

Results: 5000
    1
    2
    3

    Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 8, p. 2558, doi. 10.1007/s00259-020-05182-2
    By:
    • Westerland, Olwen;
    • Amlani, Ashik;
    • Kelly-Morland, Christian;
    • Fraczek, Michal;
    • Bailey, Katherine;
    • Gleeson, Mary;
    • El-Najjar, Inas;
    • Streetly, Matthew;
    • Bassett, Paul;
    • Cook, Gary J. R.;
    • Goh, Vicky;
    • on behalf of the Myeloma Imaging Research Group at Guy's and St Thomas' Hospital, London and King's College London;
    • Bell, Joanna;
    • Dregely, Isabel;
    • Green, Adrian;
    • Gu, Renyang;
    • Haberland, Ulrike;
    • Jeljeli, Sami;
    • Kazmi, Majid;
    • Muhidun, Nessa
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients.

    Published in:
    Cancers, 2024, v. 16, n. 17, p. 2929, doi. 10.3390/cancers16172929
    By:
    • Vigliotta, Ilaria;
    • Solli, Vincenza;
    • Armuzzi, Silvia;
    • Martello, Marina;
    • Poletti, Andrea;
    • Taurisano, Barbara;
    • Pistis, Ignazia;
    • Mazzocchetti, Gaia;
    • Borsi, Enrica;
    • Pantani, Lucia;
    • Marzocchi, Giulia;
    • Testoni, Nicoletta;
    • Zamagni, Elena;
    • Terracciano, Mario;
    • Tononi, Paola;
    • Garonzi, Marianna;
    • Ferrarini, Alberto;
    • Manaresi, Nicolò;
    • Cavo, Michele;
    • Terragna, Carolina
    Publication type:
    Article
    14

    Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial.

    Published in:
    Cancers, 2023, v. 15, n. 13, p. 3337, doi. 10.3390/cancers15133337
    By:
    • Bowcock, Stella;
    • Atkin, Catherine;
    • Iqbal, Gulnaz;
    • Pratt, Guy;
    • Yong, Kwee;
    • Neal, Richard D.;
    • Planche, Tim;
    • Karunanithi, Kamaraj;
    • Jenkins, Stephen;
    • Stern, Simon;
    • Arnott, Sarah;
    • Toth, Peter;
    • Wandroo, Farooq;
    • Dunn, Janet;
    • Drayson, Mark T.
    Publication type:
    Article
    15
    16
    17
    18
    19

    Evaluating early intervention in smoldering myeloma clinical trials: a systematic review.

    Published in:
    Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae219
    By:
    • Kakkilaya, Apoorva;
    • Trando, Aaron;
    • Cliff, Edward R Scheffer;
    • Mian, Hira;
    • Hadidi, Samer Al;
    • Aziz, Muhammad;
    • Goodman, Aaron M;
    • Jeong, Ah-Reum;
    • Smith, Wade L;
    • Kelkar, Amar H;
    • Russler-Germain, David A;
    • Mehra, Nikita;
    • Chakraborty, Rajshekhar;
    • Gertz, Morie A;
    • Mohyuddin, Ghulam Rehman
    Publication type:
    Article
    20
    21
    22
    23
    24
    25

    Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies.

    Published in:
    Cancer Medicine, 2018, v. 7, n. 8, p. 4132, doi. 10.1002/cam4.1620
    By:
    • Radocha, Jakub;
    • Maisnar, Vladimír;
    • Heindorfer, Adriana;
    • Kessler, Petr;
    • Mikula, Peter;
    • Sýkora, Michal;
    • Wróbel, Marek;
    • Pour, Luděk;
    • Krejčí, Marta;
    • Špička, Ivan;
    • Straub, Jan;
    • Minařík, Jiři;
    • Pika, Tomáš;
    • Szeligová, Lenka;
    • Hájek, Roman;
    • Pavlíček, Petr;
    • Jungová, Alexandra;
    • Jindra, Pavel;
    • Brožová, Lucie;
    • Jarkovský, Jiří
    Publication type:
    Article
    26

    Clinical significance of granule-containing myeloma cells in patients with newly diagnosed multiple myeloma.

    Published in:
    Cancer Medicine, 2016, v. 5, n. 11, p. 3051, doi. 10.1002/cam4.875
    By:
    • Suzuki, Kazuhito;
    • Yano, Shingo;
    • Nishiwaki, Kaichi;
    • Sano, Koji;
    • Shimada, Takaki;
    • Yahagi, Yuichi;
    • Ogasawara, Yoji;
    • Sugiyama, Katsuki;
    • Takahara, Shinobu;
    • Saito, Takeshi;
    • Kasama, Kinuyo;
    • Minami, Jiro;
    • Yokoyama, Hiroki;
    • Kamiyama, Yutaro;
    • Katsube, Atsushi;
    • Masuoka, Hidekazu;
    • Katori, Mitsuji;
    • Machishima, Tomohito;
    • Ouchi, Aya;
    • Dobashi, Nobuaki
    Publication type:
    Article
    27

    European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma.

    Published in:
    Leukemia & Lymphoma, 2010, v. 51, n. 11, p. 2006, doi. 10.3109/10428194.2010.516378
    By:
    • Engelhardt, Monika;
    • Udi, Josefina;
    • Kleber, Martina;
    • Spencer, Andrew;
    • Rocci, Alberto;
    • Knop, Stefan;
    • Bruno, Benedetto;
    • Bringhen, Sara;
    • Pérez-Simón, José A.;
    • Zweegman, Sonja;
    • Driessen, Christoph;
    • Patriarca, Francesca;
    • Gramatzki, Martin;
    • Terpos, Evangelos;
    • Sezer, Orhan;
    • Kropff, Martin;
    • Straka, Christian;
    • Johnsen, Hans E.;
    • Waage, Anders;
    • Boegsted, Martin
    Publication type:
    Article
    28
    29
    30
    31
    32
    33

    Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 5, p. 712, doi. 10.1007/s00259-017-3909-8
    By:
    • Nanni, Cristina;
    • Versari, Annibale;
    • Chauvie, Stephane;
    • Bertone, Elisa;
    • Bianchi, Andrea;
    • Rensi, Marco;
    • Bellò, Marilena;
    • Gallamini, Andrea;
    • Patriarca, Francesca;
    • Gay, Francesca;
    • Gamberi, Barbara;
    • Ghedini, Pietro;
    • Cavo, Michele;
    • Fanti, Stefano;
    • Zamagni, Elena
    Publication type:
    Article
    34
    35

    Approaches to Multiple Myeloma Management in Gulf Countries: A Narrative Review Insights from the Kingdom of Saudi Arabia and Gulf Multiple Myeloma Experts.

    Published in:
    Journal of Applied Hematology, 2023, v. 14, n. 2, p. 71, doi. 10.4103/joah.joah_110_22
    By:
    • Al Sharif, Fahad Z.;
    • Alhuraiji, Ahmad;
    • Alam, Arif;
    • Alhejazi, Ayman;
    • Osman, Hani;
    • El Sabah, Hesham;
    • Khan, Faraz;
    • Alahmadi, Majed;
    • Alzahrani, Musa;
    • Siddiqi, Mustaqeem A.;
    • Abdeljalil, Omar Zeid;
    • Hesham, Ahmed;
    • Rabea, Magdy;
    • Hannout, Waleed;
    • Marashi, Mahmoud
    Publication type:
    Article
    36

    Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.

    Published in:
    PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0188988
    By:
    • Sørrig, Rasmus;
    • Klausen, Tobias W.;
    • Salomo, Morten;
    • Vangsted, Annette J.;
    • Frølund, Ulf Christian;
    • Andersen, Kristian T.;
    • Klostergaard, Anja;
    • Helleberg, Carsten;
    • Pedersen, Robert S.;
    • Pedersen, Per T.;
    • Helm-Petersen, Sissel;
    • Teodorescu, Elena Manuela;
    • Preiss, Birgitte;
    • Abildgaard, Niels;
    • Gimsing, Peter;
    • null, null
    Publication type:
    Article
    37
    38
    39

    Multiple Myeloma Associated Bone Disease.

    Published in:
    Cancers, 2020, v. 12, n. 8, p. 2113, doi. 10.3390/cancers12082113
    By:
    • Rasch, Stine;
    • Lund, Thomas;
    • Asmussen, Jon Thor;
    • Lerberg Nielsen, Anne;
    • Faebo Larsen, Rikke;
    • Østerheden Andersen, Mikkel;
    • Abildgaard, Niels
    Publication type:
    Article
    40
    41

    A rare cause of hyperamylasemia: multiple myeloma.

    Published in:
    Turkish Journal of Biochemistry / Turk Biyokimya Dergisi, 2016, v. 41, n. 6, p. 479, doi. 10.1515/tjb-2016-0152
    By:
    • Sincan, Gülden;
    • Bilen, Yusuf;
    • Erdem, Fuat;
    • Gündoğdu, Mehmet
    Publication type:
    Article
    42
    43
    44

    Clinical impact of the CONUT score in patients with multiple myeloma.

    Published in:
    2020
    By:
    • Okamoto, Sho;
    • Ureshino, Hiroshi;
    • Kidoguchi, Keisuke;
    • Kusaba, Kana;
    • Kizuka-Sano, Haruna;
    • Sano, Haruhiko;
    • Nishioka, Atsujiro;
    • Yamaguchi, Kyosuke;
    • Kamachi, Kazuharu;
    • Itamura, Hidekazu;
    • Yoshimura, Mariko;
    • Yokoo, Masako;
    • Shindo, Takero;
    • Kubota, Yasushi;
    • Ando, Toshihiko;
    • Kojima, Kensuke;
    • Kawaguchi, Atsushi;
    • Sueoka, Eisaburo;
    • Kimura, Shinya
    Publication type:
    journal article
    45
    46

    Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma.

    Published in:
    Annals of Hematology, 2014, v. 93, n. 8, p. 1371, doi. 10.1007/s00277-014-2063-7
    By:
    • Huang, Shang-Yi;
    • Lin, Chung-Wu;
    • Lin, Hsiu-Hsia;
    • Yao, Ming;
    • Tang, Jih-Luh;
    • Wu, Shang-Ju;
    • Chen, Yao-Chang;
    • Lu, Hsiao-Yun;
    • Hou, Hsin-An;
    • Chen, Chien-Yuan;
    • Chou, Wen-Chien;
    • Tsay, Woei;
    • Chou, Sheng-Je;
    • Tien, Hwei-Fang
    Publication type:
    Article
    47
    48

    The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma Australia.

    Published in:
    Internal Medicine Journal, 2023, v. 53, n. 5, p. 819, doi. 10.1111/imj.16049
    By:
    • Sim, Shirlene;
    • Kalff, Anna;
    • Tuch, Gina;
    • Mollee, Peter;
    • Ho, P. Joy;
    • Harrison, Simon;
    • Gibbs, Simon;
    • Prince, H. Miles;
    • Spencer, Andrew;
    • Joshua, Douglas;
    • Lee, Cindy;
    • Ling, Silvia;
    • Murphy, Nick;
    • Szabo, Ferenc;
    • Szer, Jeff;
    • Weber, Nicholas;
    • Ward, Christopher;
    • Talaulikar, Dipti;
    • Zannettino, Andrew;
    • Quach, Hang
    Publication type:
    Article
    49
    50